Disease free-survival
Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms
... on survival of CD8+ lymphocytes in colon cancer is more obvious with longer follow-up periods ...CD8, survival curves during the first two years are very similar, further separating ...of disease ...
9
SEOM Clinical Guideline of localized rectal cancer (2016).
... advanced disease particularly those patients with potential CRM involvement [2, ...overall survival, disease-free survival and for local recurrence ...with survival outcomes ...
9
Insulin like growth factor 2 promotes ovarian cancer growth and resistance to traditional chemotherapy
... advanced disease and a poor five-year survival ...the disease recurs often and frequently develops resistance to standard ...poor survival in women with ovarian ...decreased ...
149
Aplicació de tecnologies optimitzades al diagnòstic molecular de la malaltia de von Willebrand per a l’estudi de la relació genotip-fenotip
... "Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations." Thromb Haemost 995: 91[r] ...
152
Diagnostic performance of image navigated coronary CMR angiography in patients with coronary artery disease
... Image navigator correction and gating was implemented for CMRA respiratory motion compensation. The iNAV was acquired using 10 startup echoes of the balanced steady state free precesion (bSSFP) sequence, as previ- ...
8
Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases.
... the disease in October 2015, and was rechallenged with FOLFIRI‑afliber- ...a survival of 67 months from the beginning of first‑line treatment, and 36 months following second‑line FOLFIRI‑aflibercept‑based ...
8
Metaanlisis sobre los factores pronstico relacionados con la mortalidad en nios con leucemia linfoblstica aguda
... Se utilizaron los siguientes términos MeSH (Medical Subjet Headings): precursor cell lymphoblastic leukemia- lymphoma, acute lymphoblastic leukemia, child, adolescent, mortality, survival, survival ...
15
Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.
... and survival than patients with p16-negative tumors ...failure-free survival (FFS) rates compared with patients with p16-negative tumors (OS 91% ...
9
Estudio del efecto del ácido graso de diseño LP226 en un modelo murino transgénico de la enfermedad de Alzheimer (5XFAD)
... 2017 'The hydroxylated form of docosahexaenoic acid DHA-H modifies the brain lipid composition in a model of Alzheimer's disease, improving behavioral motor function and survival', Bioch[r] ...
211
← Volver a los detalles del artículo Melanoma: análisis clínico-patológico y molecular en pacientes de la ciudad de Ibagué, Colombia
... the disease (in developing countries, patient follow-up is poor, so we have not exact data about the disease stage at the time of death) before reaching four years after ...a survival of less than ...
14
Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model
... McArdle disease is an autosomal recessive disorder caused by the absence of the muscle glycogen phosphorylase, which leads to impairment of glycogen ...characterize disease progression at three different ...
14
Eficacia de la quimioterapia intratecal con triple droga en pacientes con leucemia linfoide aguda
... event-free survival when compared with intrathecal methotrexate: results of the Children´s Cancer Group (CCG)1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children’s Oncology ...
5
Free Better Than Free
... Accessibility: ownership often sucks. you have to keep your things tidy, up-to-date, and in the case of digital material, backed up. and in this mobile world, you have to carry it along with you. many people, me ...
11
Organic carbon enhances dark survival of the cyanobacterium Geitlerinema sp isolated from black band disease of corals
... band disease (BBD) of corals is characterized as a pathogenic, horizontally migrating micro- bial mat that is dominated by gliding, filamentous ...of survival supported by exogenous organic carbon sources ...
8
IKAROS Gene Deleted B Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature
... Ph chromosomal abnormality was the first one de- scribed in association with chronic myeloid leukemia (CML) and linked with malignant disease. It is the most characteristic structural chromosome alteration in CML, ...
5
Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer.
... The lack of association to CRC predisposition did not exclude the possibility of correlation with a different heritability of CRC. To test this hypothesis, haplotype frequencies were analyzed together with the age of CRC ...
7
Full PDF
... transplant survival documented in this study was simi- lar to but lower than that reported in the only other long-term study of reattached ...fragment survival between the two studies narrowed from year-2 ...
12
Landscapes of Survival
... Y a la vez en esos materiales, esos cuerpos entre lo vivo y lo muerto, entre lo animado y lo inanimado, entre el organismo y las líneas minerales, calcáreas[r] ...
16
Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis
... However, clinicians have limited instruments available for the early detection of breast cancer recurrence that results from metastases undetected at the time of the pri- mary treatment. Molecular studies have yielded ...
9
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial
... Patients at least 18 years of age with HER2-negative ad- vanced breast cancer who have been treated with a max- imum of one prior chemotherapy regimen for metastatic disease are eligible to enroll. Prior treatment ...
8